Protective effects of Fenofibrate on renal ischemia-reperfusion injury in rats

Jiong Zhang,Jia wang,Guisen Li,Fang Wang
DOI: https://doi.org/10.3969/j.issn.1000-744X.2018.02.001
2018-01-01
Abstract:Objective o study the protective effect and possible mechanism of Fenofibrate on renal ischemia-reperfusion injury in rats. Methods 30 rats were randomly divided into sham operation group, ischemia reperfusion injury group and Fenofibrate group, 10 rats in each group. A rat model of renal ischemia-reperfusion injury was made by clamping the bilateral renal pedicle of blood vessel, and the drug was injected intraperitoneally(300 mg/kg)45 minutes after ischemia. Renal catalase was detected by xanthine oxidase(CAT), glutathione peroxidase(GPx)and superoxide dismutaseCSOD)activity. Rrenal malondialdehyde thiobarbituric acid (MDA) expression was detected by TBA. Serum creatinine(Cr), urea nitrogen(BUN) tumor necrosis factor(TNF-a) and interleukin-6 (IL-6) and interleukin-8(IL-8)expression were detected by enzyme linked immunosorbent assay(ELISA). By reverse transcription polymerase chain reaction (RT-PCR) detection of TNF-α, IL-6 messenger RNA and IL-8(mRNA)level. Renal pathology was detected by PAS staining. Expression detection of PPAR-α8in renal tissue and alpha p-PPAR-alpha were detected by western blot technique (WB). Results Compared with ischemia-reperfusion group, fenofibrate group CAT, GPX and SOD activity increased, p-PPAR-α expression was significantly upregulated, while TNF-a, IL-6, IL-8, Cr, BUN and MDA expression levels were significantly lower in renal pathological changes also decreased significantly and PPAR- alpha expression level there were no statistical significantly differences. Conclusion Fenofibrate can attenuate renal ischemia reperfusion injury by activating PPAR-α, and its mechanism is related to the inhibition of oxidative stress and inflammation.
What problem does this paper attempt to address?